Amgen dismisses bone density concerns related to its weight-loss drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company's market value.
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.
New weight loss drug 'burns calories' without sickness, research says
A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The discovery could lead to a new treatment for millions of people with both obesity and type 2 diabetes who do not respond well to current treatments, according to experts.
Weight-loss drugs can help stroke survivors prevent recurrence
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental health challenges. Her story, here.
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.
Amgen rebounds after denying bone safety concerns linked to obesity drug
Amgen (NASDAQ:AMGN) shares spiked in the premarket on Wednesday after the company ruled out concerns over loss of bone mineral density linked to its obesity candidate MariTide, which led to a ~7% decline in its share price in the previous session.
Medical Xpress18h
New weight loss drug target burns energy and lowers appetite—without the nausea and vomiting
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, ...
New study suggests weight loss drugs like Ozempic could help with knee pain. Here’s why there may be a link
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
Men's Journal on MSN2h
Jim Gaffigan Reflects on Weight Loss Journey, How He Finally Slimmed Down
It was my reward," he recalled, also admitting that he's aware of the stigma around the decision to use weight loss drugs. ...
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
SFGate4h
Weight loss plans are less effective for many Black women − because existing ones often don’t meet their unique needs
(THE CONVERSATION) The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans’ desire to slim down. While these new drugs have offered a solution for people ...
Hosted on MSN6h
Amgen dismisses bone density concerns related to its new weight-loss drug
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone ...
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...